GlaxoSmithKline S.A.E. (BIOC.CA)

Also known as:  GSK Egypt, GlaxoSmithKline Egypt
Data delayed by 15 minutes
19.76 EGP 0.000.00%
As of 01 DEC 2019 - GMT|Egypt SE

GSK Egypt Stock Price & Performance Powered By Knowledge Direct

Recommendation
-
Div Yield
2.277%
P/E (Last 12 Month)
45.384
Upside
-
Target Price (Mean)
-
52Wk
17.79 01 DEC
17.79 01 DEC

Open
Data not available
Previous Close
19.76 EGP
Turnover
Data not available
EPS
-
Volume
0
Transactions
0
Market Cap
1.65B EGP
IPO Date
01-Sep-1993
Analyst Recommendation
Sell
Hold
Buy
Analyst Rating
Strong Buy
Buy
Hold
Sell
Strong Sell

About GlaxoSmithKline S.A.E.Last updated on: 15 January 2018

Business Summary
Manufacture of branded and generic drugs, chemicals, veterinary, vitamins and nutritional products, pharmaceutical and bulk drugs substance.
Country of Incorporation
Ownership Type
Established In
1981
Primary Sector
Number of Employees
1000
Stock Listing
IDStock TypeCurrencyExchangeSymbol
BIOC.CASEOrdinaryEGPEgypt SEBIOC

Contact details

Primary address
Boomerang Building 46, Block J
Ninety Street
1st-3rd Floor
5th Settlement
41
Egypt
Cairo
11835
CONTACT
  • Tel: +20 2-2618-5000
  • Fax: +20 2-2618-5001
Region
Cairo
All Related News

Saudi Arabia is magnet for foreign investors

A recent World Bank report highlighted the Kingdom’s continued efforts to improve the business climate for domestic and medium-sized businesses

Arab News - Sunday 8 December 2019
All Health Care News
All Markets News

Ownership

Revenue
Net Income
Profit Margin
Total Assets
Total Liabilities
Debt to Assets
Operating
Investing
Financing

Executives

Dr Amro Mohammed Mamdouh Abdulmajid
Managing Director
Dr Ashraf Mohammed Ibrahim Mansour
Medical and Regulatory Director
Mr Amro Abou Naja
Marketing Director

Board Members

Dr Amro Mohammed Mamdouh Abdulmajid
Chairman and director representing GlaxoSmithkline Plc
Dr Ashraf Mohammed Ibrahim Mansour
Director director representing GlaxoSmithkline Plc
Mr Jude Albert Brajanza
Director representing GlaxoSmithkline Plc
All People

Company information provided by © 2019 Thomson Reuters

Thomson Reuters research team update company information from primary sources (company annual reports, press releases, company websites, corporate briefings, official statements/interviews) and reliable secondary sources (stock markets, reliable third party publications).

Peers

StocksLast Price% Change
CAIRO PHARMAC.39.470 EGP0.00
EGYPT INTL PHRM69.000 EGP0.00
ALX. PHARMACEUT.100.000 EGP0.00
MINAPHARM PHARMA84.950 EGP0.00
ARAB PHARM40.940 EGP0.00
All Peers

Most Viewed Stocks

Stock Market Data

Powered By Knowledge Direct

Stock Screener

All Stocks